Henshaw Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $538K | Hold |
2,475
| – | – | 0.02% | 151 |
|
|
2025
Q4 | $566K | Hold |
2,475
| – | – | 0.02% | 150 |
|
|
2025
Q3 | $573K | Hold |
2,475
| – | – | 0.02% | 161 |
|
|
2025
Q2 | $459K | Hold |
2,475
| – | – | 0.02% | 244 |
|
|
2025
Q1 | $519K | Hold |
2,475
| – | – | 0.02% | 226 |
|
|
2024
Q4 | $440K | Hold |
2,475
| – | – | 0.02% | 238 |
|
|
2024
Q3 | $489K | Hold |
2,475
| – | – | 0.02% | 223 |
|
|
2024
Q2 | $425K | Hold |
2,475
| – | – | 0.02% | 195 |
|
|
2024
Q1 | $451K | Hold |
2,475
| – | – | 0.02% | 187 |
|
|
2023
Q4 | $384K | Hold |
2,475
| – | – | 0.02% | 206 |
|
|
2023
Q3 | $369K | Hold |
2,475
| – | – | 0.02% | 195 |
|
|
2023
Q2 | $333K | Hold |
2,475
| – | – | 0.02% | 166 |
|
|
2023
Q1 | $394K | Hold |
2,475
| – | – | 0.02% | 146 |
|
|
2022
Q4 | $400K | Hold |
2,475
| – | – | 0.03% | 138 |
|
|
2022
Q3 | $332K | Hold |
2,475
| – | – | 0.02% | 190 |
|
|
2022
Q2 | $379K | Hold |
2,475
| – | – | 0.03% | 176 |
|
|
2022
Q1 | $401K | Hold |
2,475
| – | – | 0.02% | 193 |
|
|
2021
Q4 | $335K | Buy |
2,475
+475
| +24% | +$56.1K | 0.02% | 236 |
|
|
2021
Q3 | $216K | Hold |
2,000
| – | – | 0.01% | 310 |
|
|
2021
Q2 | $225K | Hold |
2,000
| – | – | 0.01% | 330 |
|
|
2021
Q1 | $216K | Hold |
2,000
| – | – | 0.01% | 325 |
|
|
2020
Q4 | $214K | Sell |
2,000
-44,550
| -96% | -$4.28M | 0.02% | 322 |
|
|
2020
Q3 | $4.08M | Buy |
46,550
+44,000
| +1,725% | +$4.14M | 0.32% | 45 |
|
|
2020
Q2 | $250K | Buy |
+2,550
| New | +$225K | 0.02% | 248 |
|
|
2020
Q1 | – | Sell |
-2,550
| Closed | -$226K | – | 282 |
|
|
2019
Q4 | $226K | Buy |
+2,550
| New | +$212K | 0.02% | 247 |
|
Other funds holding ABBV
VCM
VPM
